756 - LA ART: Ready for Use in High-Risk Populations? Pro/Con

Thursday, October 20, 2022

3:15 PM – 3:50 PM US ET

Location: 146 ABC

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Speaker(s)

Aadia Rana, MD

Associate Professor of Medicine
University of Alabama-Birmingham School of Medicine
Birmingham, AL, United States

Disclosure: Disclosure(s): Merck and Company, Inc.: Grant/Research Support (Terminated)
Sara H. Bares, MD

Associate Professor, Division of Infectious Diseases
University of Nebraska Medical Center
Omaha, Nebraska, United States

Disclosure: Disclosure(s): Gilead Science: Advisor/Consultant (Terminated); Janssen Infectious Disease: Grant/Research Support (Ongoing); The GSK group of companies: Grant/Research Support (Ongoing)

Disclosure(s):

Aadia Rana, MD: Merck and Company, Inc.: Grant/Research Support (Terminated)

Sara H. Bares, MD: Gilead Science: Advisor/Consultant (Terminated); Janssen Infectious Disease: Grant/Research Support (Ongoing); The GSK group of companies: Grant/Research Support (Ongoing)